Home
XP Asset Management

XP Asset Management Market Share Analysis for November 2025

relações com investidores

Finance > Investing

Domainxpasset.com.br

Year Founded2006

Employees51 - 200

Annual Revenue--

XP Asset Management

XP Asset Management (including company regionals)

xpasset.com.br

See more website traffic and engagement information

Total visits to XP Asset Management's top domains

Understand XP Asset Management market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

xpasset.com.br16.6K

See more with Sales Intelligence

Avg. visit duration in XP Asset Management's top domains

Analyze XP Asset Management engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

xpasset.com.br00:00:41

See more with Sales Intelligence

Avg. pageviews on XP Asset Management's top domains

See how XP Asset Management keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

xpasset.com.br1.80

See more with Sales Intelligence

XP Asset Management top competitors by domain

Top similar sites in November 2025, ranked by their affinity

euqueroinvestir.comCompany NameEu Quero InvestirEmployees201 - 500HQBrazil, Balneário De CamboriúAnnual revenue$50M - $75MTotal visits34.9KFinance > Investing

Top technologies used by XP Asset Management

These are the website technologies, by industry, used by XP Asset Management top domains

Advertising (9)

Google Adsense

Conversion & Analytics (9)

Google Analytics

Widget (5)

reCAPTCHA

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from XP Asset Management

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsXpasset invests into Superbac $62.6M.The largest funding rounds during this period were: Superbac Biotechnology Solutions, a Brazilian biotech, raised US$ 62,633,100 in a round led by XP Asset Management - this was the largest ever investment in a Latin American biotech.